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Calcineurin (Cn) is a serine/threonine protein
phosphatase that plays pivotal roles in many
physiological processes, including cell prolifer-
ation, development, and apoptosis. Most prom-
inently, Cn targets the nuclear factors of acti-
vated T cell (NFATs), transcription factors that
activate cytokine genes. Calcium-activated Cn
dephosphorylates multiple residues within the
regulatory domain of NFAT, triggering joint nu-
clear translocation. This relies crucially on the
interaction between the catalytic domain of Cn
(CnCat) and the conserved PxIxIT motif located
in a region distinct from the dephosphorylation
sites of NFAT. Here, we present the structure of
the complex between the 39 kDa CnCat and
a 14 residue peptide containing a PVIVIT seg-
ment that was derived from affinity-driven pep-
tide selection based on the conserved PxIxIT
motif of NFATs. The structure of the complex
was determined by using NMR assignments
and structural constraints and the coordinates
of the CnCat crystal structure. The NMR analy-
sis relied on recently developed labeling and
spectroscopic techniques. The VIVIT peptide
is accommodated in a hydrophobic cleft
formed by b strands 11 and 14, and the loop
between b strands 11 and 12, forming a short
parallel b sheet with the exposed b strand 14
in Cn. The side chains of conserved residues
in the PxIxIT sequences make extensive inter-
actions with conserved residues in Cn, while
those of nonconserved residues are solvent
exposed. The architecture of the interface
explains the diversity of recognition sequences
compatible with NFAT function and uncovers a
potential targeting site for immune-suppressive
agents. The structure reveals that the orienta-
tion of the bound PxIxIT directs the phosphory-Structure 15,lation sites in NFAT’s regulatory domain toward
the Cn catalytic site.
INTRODUCTION
Calcineurin (Cn) is a heterodimeric phosphoprotein serine/
threonine phosphatase that is activated by Ca2+/calmod-
ulin (Figure 1A). The active site of calcineurin is located in
the CnA subunit, which is 57–59 kDa in mammals, and
is regulated by interaction with the 19kDa CnB subunit
(Rusnak and Mertz, 2000). CnA has one Zn and one Fe
ion in the catalytic core, and both metals are indispens-
able for catalytic activity (Mondragon et al., 1997). Cn
was originally identified as a major calmodulin-binding
protein in the brain (Klee et al., 1979; Stewart et al.,
1982) but has since been shown to play pivotal roles in
a wide variety of other biological contexts, such as regula-
tion and development of the immune, nervous, cardiovas-
cular, and musculoskeletal systems, and to be involved in
apoptosis and necrosis (Aramburu et al., 2000, 2004;
Clipstone and Crabtree, 1992; Hemenway and Heitman,
1999; Hogan and Li, 2005; Rusnak and Mertz, 2000).
The most studied role of Cn is its role in T cell signaling.
Increased intracellular calcium levels activate Cn, which
causes it to dephosphorylate multiple residues in nuclear
factors of activated T cells (NFATs) (Jain et al., 1993).
Phosphorylation sites are located in NFAT’s regulatory
domain in three different serine-rich motifs, termed SRR1,
SP2, and SP3 (Figure 1B). Dephosphorylation of these
serine residues is thought to cause exposure of nuclear
localization signal sequences triggering translocation of
the dephosphorylated NFAT-Cn complex to the nucleus,
where NFAT activates target gene expression (e.g., IL2)
(Rao et al., 1997). The DNA-binding domain of NFAT is
located in the REL-homology region (RHR), which also
contains the binding sites for activator protein 1 (AP1) pro-
teins, such as FOS and JUN. The structures of RHR alone,
and the RHR-DNA and RHR-DNA-FOS-JUN complexes,
which have been determined with NMR and/or X-ray crys-
tallography, revealed the cooperativity aspects of tran-
scriptional activation by NFAT (Chen et al., 1998; Wolfe
et al., 1997; Zhou et al., 1998). Due to its role in T cell
activation, Cn has been targeted for the development of587–597, May 2007 ª2007 Elsevier Ltd All rights reserved 587
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Structure of the Calcineurin-NFAT ComplexFigure 1. Schematic Representation of the Domain Structure of Human Calcineurin and Human NFAT2
(A) For CnA, the locations of the binding sites for CnB, calmodulin (CaM), and the autoinhibitory domain (AI) are indicated with gray boxes. For CnB,
four EF hand motifs are indicated.
(B) The location of the calcineurin binding site, the serine-rich region 1 (SRR1), the SPxx-repeat motifs 2 and 3 (SP2 and SP3), and nuclear localization
and export signals of hNFAT2 are indicated.immune-suppressant drugs. The two most successful Cn
inhibitors discovered so far, cyclosporin A (CsA) and
tacrolimus (FK506), block Cn’s phosphatase activity by
obscuring its catalytic site. They are presented as stable
trimeric complexes with the intracellular proteins cyclo-
philin and FKBP12, respectively (Griffith et al., 1995;
Huai et al., 2002; Kissinger et al., 1995). Although highly
successful, CsA and FK506 have severe potential side
effects, which may be due to intrinsic toxicity; more likely,
however, these effects result from the general inhibition of
the enzymatic activity of Cn, which plays other biologically
important roles besides NFAT activation (Kiani et al.,
2000).
It is known that Cn-NFAT signaling depends on an inter-
action between the Cn catalytic domain (CnCat) and the
conserved PxIxIT motif, which is located N-terminal to
the phosphorylation sites in NFAT’s regulatory domain
(Aramburu et al., 1998) (Figure 1B). Interfering with the
Cn-NFAT interaction by mutating the conserved sequence
impairs NFAT’s activation capabilities (Aramburu et al.,
1998). While the interaction between CnCat and the PxIxIT
motif of NFAT is indispensable for NFAT activation, it does
not depend on the polypeptide segment containing the
phosphorylation sites (Aramburu et al., 1998; Garcia-
Cozar et al., 1998). Based on the topologies of this inter-
action, an alternative strategy for more specific inhibition
of Cn-NFAT signaling has been proposed by targeting
the NFAT interaction site rather than the enzyme’s cata-
lytic site, in order to achieve selectivity in suppressing
T cell activation (Roehrl et al., 2004a, 2004b). Affinity
selection from a consensus PxIxIT sequence-based com-588 Structure 15, 587–597, May 2007 ª2007 Elsevier Ltd All ribinatorial peptide library showed that Cn is able to accom-
modate a variety of sequences without significantly losing
their affinity and some of the selected peptides had
a higher Cn binding affinity than the original NFAT se-
quences (Aramburu et al., 1999). While the native targeting
sequences have relatively low affinity for Cn (Kd 20 mM
for SPRIEIT sequence in NFAT1), the best selected pep-
tide with the sequence VIVIT at the center exhibits a 50-
fold higher affinity for Cn (Aramburu et al., 1999). Efforts
to identify the VIVIT peptide binding site with X-ray crystal-
lography have failed so far because crystals cracked after
the soaking with the peptide in various Cn crystal forms
(Roehrl et al., 2004a, 2004b). This observation suggested
that the VIVIT peptide might bind to a conserved crystal
contact site, which maps to a conserved hydrophobic
surface around b strand 13 (319–325) and b strand 14
(328–334), and the idea was recently supported by a com-
bination study of photoaffinity crosslinking, mutation, and
in silico docking simulations (Li et al., 2004).
To obtain a more detailed picture of the Cn-NFAT inter-
action, we have determined the structure of Cn-VIVIT pep-
tide complex by using solution NMR techniques. The VIVIT
peptide binds to the exposed b strand 14 while forming
a short parallel b sheet. The conserved hydrophobic side
chains of the PxIxIT motif are located in a hydrophobic
cleft formed by b strands 11 and 14 and the b11-b12
loop (i.e., the loop between b strand 11 and 12). On the
other hand, nonconserved residues in the PxIxIT motif
are largely exposed to solvent. These results provide a
detailed view of NFAT recognition by Cn and reveal the
mechanism by which Cn specifically recognizes theghts reserved
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Structure of the Calcineurin-NFAT ComplexFigure 2. 1H-15N TROSY HSQC Spectra of 2H15N-Labeled CnCat
The spectra without and with the 14-mer VIVIT peptide are shown in red and black, respectively. For the spectrum with the VIVIT peptide, a 1.2-fold
excess of peptide was added to 2H15N-labeled CnCat.conserved PxIxIT sequence. The information is potentially
useful for developing new bioactive compounds that
target Cn-NFAT interaction.
RESULTS AND DISCUSSION
Identification of the VIVIT Binding Site on Calcineurin
The 39 kDa catalytic domain of calcineurin, which includes
residues 2–347, was prepared based on the method
developed by Aramburu et al. with minor modifications
(Aramburu et al., 1999). As shown in Figure 2, the TROSY
1H-15N HSQC spectrum of CnCat is well dispersed, re-
flecting the a-b mixed structure of the CnCat domain
(Griffith et al., 1995; Huai et al., 2002; Jin and Harrison,
2002; Kissinger et al., 1995). About 210 resonances out
of 326 expected resonances are identified in the TROSY
1H-15N HSQC spectrum of perdeuterated CnCat. One
explanation for the absence of some of the resonances
is insufficient D/H exchange after expression of the protein
in D2O. The other possibility is the paramagnetic effect,
since CnCat possesses a paramagnetic iron (Fe3+ or
Fe2+) in its catalytic center. To ascertain the main cause
for the missing resonances, we utilized a partial deutera-
tion strategy where the protein was cultured on deuter-
ated media but in H2O to avoid the back exchange prob-
lem (Lohr et al., 2003). This strategy, however, rescued
only 20 additional resonances out of the 110 missing
signals, indicating that paramagnetic effect, rather than
insufficient back exchange, is the primary reason for the
missing resonances. Indeed, the results of our main-chainStructure 15, 5assignments of the protein revealed that resonances orig-
inating from any hydrogens within a 10 A˚ distance from the
iron in the catalytic center of CnCat could not be observed.
Upon the addition of VIVIT peptide, CnCat resonances
showed chemical shift perturbations indicative of the
slow-exchange kinetics, confirming that the VIVIT peptide
forms a stable complex with CnCat. The chemical shift
changes were saturated at a 1:1 stoichiometric amount
of peptide to protein indicating a 1:1 complex between
CnCat and the VIVIT peptide. Main-chain resonances of
CnCat in complex with VIVIT peptide were assigned with
the data from standard TROSY triple-resonance experi-
ments and information from selective labeling. Comparing
the spectra of free and bound CnCat, we identified the res-
onances shifted upon binding of the VIVIT peptide (peaks
shifted more than half peak width). Figures 3B and 3C
show the distribution of the residues affected by VIVIT
binding. Chemical shift changes were observed for >30
resonances, which reside in the C terminus of helix 3 (res-
idue number 72–74), b strand 1 (79), the C-terminal side of
helix 4 (103–106), the H4-b3 loop (i.e., the loop between
helix 4 and b strand 3) (111), b strand 3 (114), the b5-b6
turn (192–194), the b7-b8 loop (240 and 242), the C termi-
nus of helix 12 (271 and 272), b strand 10 (277), the b11-
b12 loop (293, 294, 296, 298, and 299), and b strands 13
and 14 (324–335). Most of these residues are mapped
into a contiguous surface, which includes two (lower and
upper) clefts on the CnCat structure (colored in magenta
in Figure 3C). The lower cleft includes the C terminus of
helix 3 and b strand 13, while the upper cleft includes87–597, May 2007 ª2007 Elsevier Ltd All rights reserved 589
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Structure of the Calcineurin-NFAT ComplexFigure 3. Summary of VIVIT Peptide-
Binding Experiments for CnCat
(A) Intensity reduction ratio for each resonance
in the cross-saturation experiment. A satura-
tion time of 300 ms was applied to the methyl
proton resonances of the VIVIT peptide. The
residues that experienced a significant inten-
sity reduction are colored in red. The error
bars are estimated from the signal-to-noise
ratios of the resonances analyzed.
(B and C) Sites perturbed by the binding of
VIVIT are mapped on the ribbon (B), and sur-
face (C), of the CnCat structure. Red spheres
or surfaces indicate the sites that experienced
both cross-saturation and chemical-shift per-
turbations. Yellow indicates the sites that
showed chemical-shift changes upon VIVIT
binding. Blue residues were not affected in
both experiments. White surfaces were not
assigned. Magenta shadows in (C) indicate
the positions of the two clefts on the CnCat
structure.the b strands 11 and 14 and the b11-b12 loop. The types of
amino acids that line these two clefts are significantly dif-
ferent. The upper cleft consists of hydrophobic or aro-
matic residues, while the lower cleft is lined primarily by
hydrophilic and charged residues. The total solvent-cces-
sible surface area for the shifted residues is 1400 A˚, which
is much larger than what a single 14-mer peptide can
cover. Given the fact that the peptide and the protein
form a 1:1 complex, it seems that CnCat has a secondary
site that allosterically changes its structure upon the bind-
ing of the NFAT peptide to its cognate site. The overall
structure of CnCat, however, doesn’t seem to change
significantly since the global features of the spectra do
not alter dramatically upon VIVIT binding. To identify the
direct VIVIT binding site, a cross-saturation experiment
was performed for 2H15N CnCat in complex with unlabeled
VIVIT peptide. Selective irradiation to the methyl reso-
nances of VIVIT caused a significant signal intensity loss
for the resonances of Met329 and Ile331 on b strand 14
(Figure 3A). The data strongly indicate that the upper cleft
rather than lower cleft is the direct binding site of VIVIT
(Figure 3C). Moreover, since the upper cleft consists
mostly of hydrophobic residues, the nature of the cleft is
also favorable for accommodating the hydrophobic VIVIT
peptide.590 Structure 15, 587–597, May 2007 ª2007 Elsevier Ltd All rigIdentification of the Cn Binding Site
on the VIVIT Peptide
For precise identification of the CnCat-binding sequence
on the VIVIT peptide, the main-chain resonance assign-
ment of the free VIVIT peptide and in complex with CnCat
was accomplished with triple-resonance experiments
(Figure 4). The VIVIT peptide binds with slow-exchange
kinetics, which is consistent with the features observed
on the CnCat side. As shown in Figure 4A, the region
from Ile6 to Gly10 experiences a significant downfield shift
upon binding, indicating that this segment forms an
extended secondary structure in the complex. This obser-
vation was also supported by the upfield shift of Ca reso-
nances upon binding to CnCat (data not shown). Val5
exhibited a significant downfield chemical-shift change.
Figure 4B displays the normalized chemicals shift for
amide resonances ([DdH2 + (DdN / 5)2]1/2) of VIVIT peptide
upon binding to CnCat (upper). The lower panel reports
the result of cross-saturation for the same complex. The
region from Val5 to Gly10 showed >0.2 ppm chemical-
shift changes and was also strongly saturated in the
cross-saturation experiment, indicating the region binds
tightly to the CnCat. His12 also showed a modest chemi-
cal shift perturbation, while the regions before His3 or after
Glu13 do not seem to interact with the protein.hts reserved
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Structure of the Calcineurin-NFAT ComplexStructure of the CnCat-VIVIT Complex
To obtain a detailed view of the Cn-NFAT interaction, we
then set out to determine the structure of the Cn-VIVIT
peptide complex by simulated annealing of the VIVIT pep-
tide in the presence of the X-ray structure of free CnCat
(PDB code: 1AIU) using structural information derived
from NMR spectroscopy. In total, we used 22 intermole-
cular distance restraints, 52 intramolecular distance re-
straints within the VIVIT peptide, and 9 main-chain angular
Figure 4. Summary of CnCat-Binding Experiments for VIVIT
Peptide
(A) 1H-15N TROSY HSQC spectra of 2H15N-labled VIVIT peptide with-
out (red) and with (blue) CnCat. The free and bound resonances are
connected by a dotted line with the assignments.
(B) Upper panel: normalized chemical-shift perturbation upon binding
to CnCat. Lower panel: intensity reduction ratio for each resonance
in the cross-saturation experiment. A saturation time of 300 ms was
applied for the methyl proton resonances of CnCat.Structure 15,constraints for I6-G10 in the VIVIT peptide. Taking advan-
tage of the knowledge of the VIVIT binding site on CnCat,
the side chains of the residues forming the VIVIT peptide
binding site in CnCat were allowed to be flexible during
the simulation. Other parts of CnCat were tightly re-
strained by distance and angular constraints calculated
from the X-ray structure of free CnCat.
Figure 5A shows a set of converged structures of the
Cn-VIVIT complex based on the structural restraints
derived from NMR experiments. The VIVIT binding site is
located on the side of the CnCat molecule. There is no
VIVIT peptide atom within 18 A˚ distance from the catalytic
core iron, which may explains how the peptide inhibits
NFAT binding without affecting the catalytic activity of
CnCat (Aramburu et al., 1998). The total buried surface
area of the peptide is 698 ± 70 A˚2, which corresponds to
32% ± 3% of the total exposed surface of the peptide.
The conserved PxIxIT sequence of the VIVIT peptide is
particularly well ordered in the structure. The root-mean-
square deviation values are 0.68 ± 0.32 A˚ and 1.15 ±
0.39 A˚ for main-chain and all heavy atoms, respectively,
in this region, due to the extensive number of experimental
constraints applied (see Figure S1 available with this arti-
cle online). The VIVIT peptide binds on the exposed b
strand 14 of CnCat forming a short four-residue parallel
b sheet (Ile6 to Thr9) (Figures 5B and 5C). The parallel
b sheet structure is supported by interstrand NOEs shown
in Figure 5C. In the calculated structures, intermolecular
main-chain hydrogen bonds are observed for M329
(CO)-V7 (HN) (7/10), I331 (HN)-V7 (CO) (10/10), and I331
(CO)-T9 (HN) (10/10). The VIVIT peptide forms a bend
at the N-terminus of the conserved sequence between
Pro4 and Val5. This bend allows for contact between
the N-terminus of the peptide and the b11-b12 loop.
Figure 6A shows the surface of CnCat with the color rep-
resentation derived from NMR-binding experiments. The
results of the cross-saturation experiment reliably identify
the region corresponding to the core VIVIT binding site,
where a tight interaction between the peptide and the
protein occurs. In contrast, chemical-shift perturbation
experiments also report weak interacting regions such
as the b11-b12 loop, where the N terminus of the peptide
interacts, or the lower cleft shown in Figure 3C, which
apparently senses allosteric effects. It is also known that
mutations to the linker region joining the catalytic domain
and the regulatory domain of Cn (S337P, H339L, or L343S)
disrupt the binding of Cn to NFAT1 (Rodriguez et al.,
2005). Since there is no atom from the bound VIVIT pep-
tide within 6 A˚ from these mutated residues, there appears
to be no direct interaction between the linker region and
the VIVIT peptide. However, because the mutated resi-
dues are C-terminal to the VIVIT binding b strand 14 of
CnCat, these mutations might allosterically affect the
structure of the VIVIT binding site in CnCat and disrupt
the binding between Cn and NFAT.
Architecture of the PxIxIT/Cn Interface
Figures 6B and 6C show enlarged views of the binding site
of the conserved PxIxIT motif with a color representation587–597, May 2007 ª2007 Elsevier Ltd All rights reserved 591
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Structure of the Calcineurin-NFAT ComplexFigure 5. NMRModel of the CnCat-VIVIT
Peptide Complex
(A) Stereo view of an ensemble of ten final NMR
structures of the CnCat-VIVIT peptide com-
plex. Blue lines show the backbone trace of
CnCat. Red lines show the backbone trace of
the VIVIT peptide with the side-chain heavy
atoms for the PxIxIT motif (i.e., Pro4-Thr9).
(B) Ribbon representation of the CnCat-VIVIT
peptide complex with the lowest energy func-
tion.CnCat is shown in light blue,and VIVIT pep-
tide is shown in red with side chains for the
PxIxIT motif. In (A) and (B), the two metal ions
are shown as spheres (yellow, Fe; purple, Zn).
(C) A schematic representation of the second-
ary structure elements in the CnCat-VIVIT pep-
tide complex. The hydrogen bonds observed in
the structure are marked by black dotted lines.
Blue dotted arrows indicate the observed inter-
strand NOEs.based on the property of residues. The VIVIT binding site
on Cn is very hydrophobic and forms several hydrophobic
pockets in CnCat structures. As shown in Figure 6B and
the cartoon of Figure 6D, Phe195 in b strand 6, Tyr324 in
b strand 13, and M329 and Ile331 in b strand 14 of CnCat
form the base of the hydrophobic pockets. Leu275 in the
H12-b11 loop, and Pro300 in the b11-b12 loop define
the boundary of the hydrophobic regions. Tyr288 and
Met 290 in b strand 11 and Phe299 in the b11-b12 loop
separate this section into three hydrophobic pockets. All
residues that form the hydrophobic pockets are con-
served among different species. Each of the conserved
hydrophobic pockets accommodates one of the residues
from the conserved motif in the VIVIT peptide. Pro4 in the
VIVIT peptide fits into a hydrophobic cleft between Leu275
and Phe299 of CnCat. Ile6 is the least exposed residue
(10% of the total surface is exposed) in the conserved mo-
tif, and a hydrophobic pocket formed by Met290, Phe299,
Pro300, and Met328 in CnCat accommodates the side
chain of Ile6. Ile8 is sandwiched between Tyr288 and
Met290 and forms an extensive interaction with Ile331 in
a nested rearrangement (Wouters and Curmi, 1995). Mu-
tation of Ile331 to Ala is known to reduce the affinity of
the peptide to protein by more than 20-fold, indicating
that the side-chain hydrophobic interaction between
these residues is energetically important (Li et al., 2004).592 Structure 15, 587–597, May 2007 ª2007 Elsevier Ltd All rigAlthough, Ile6 and Ile8 are conserved within NFATs, these
interaction sites can potentially accommodate a different
type of amino acid residue with hydrophobic properties.
Indeed, it has been shown that even the least exposed
Ile6 can be mutated to Phe, Val, or Leu without signifi-
cantly loosening the affinity to CnCat (Aramburu et al.,
1999). Two valine residues (Val5 and Val7) in between
these conserved residues are oriented toward the solvent,
allowing extensive substitution of these residues. The po-
sitions corresponding to Val5/Val7 is Arg/Glu in hNFAT1
and hNFAT2, Ser/Arg in hNFAT3, and Ser/Gln in hNFAT4.
In a similar recognition motif in the calcineurin inhibitor
Cabin1, the corresponding residues are Glu/Thr. How-
ever, since Val328 in b strand 14 of CnCat makes hydro-
phobic contacts with Val5 and Val7, hydrophobic residues
may be more preferable compared to the native hydro-
philic sequences. This might be one of the reasons why
the VIVIT sequence has a higher affinity relative to native
sequences. Thr9 of the VIVIT peptide is exposed despite
being conserved within NFATs. As shown in Figure 6C,
Thr9 is in close proximity to Asn330 and Arg332, both of
which are conserved in CnCat. Indeed, the energetic inter-
action between the side chains of Thr9 and Asn330 is
shown by mutational analysis (Li et al., 2004). Since the
g-hydroxyl group of Thr9 is observed in some of our struc-
tures to form hydrogen bond with the side-chain amide ofhts reserved
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Structure of the Calcineurin-NFAT ComplexFigure 6. Interface of the CnCat-VIVIT Peptide Interaction
(A) Sites that are perturbed by the binding of the VIVIT peptide are mapped on the CnCat surface in the CnCat-VIVIT peptide complex. Red surfaces
indicate sites that experienced both cross-saturation and chemical-shift perturbation. Yellow indicates the sites that showed chemical-shift changes
upon binding of the VIVIT peptide. Blue residues were not affected in both experiments. White surfaces were not assigned. The VIVIT peptide is shown
as a ribbon representation with the side chains for the PxIxIT motif.
(B) and (C) show the interface of CnCat and the conserved PxIxIT motif. In (B), the conserved residues in CnCat are shown with a colored surface
representation based on the properties of each amino acid. Hydrophobic, acidic, basic, and hydrophilic residues are shown in yellow, red, blue,
and white, respectively. The VIVIT peptide is shown as a ribbon representation with stick representation for the side-chain heavy atoms of the PxIxIT
motif. The conserved Pro4, Ile6, Ile8, Thr9 are shown in dark red, while nonconserved Val6 and Val8 are colored in pink. In (C), the conserved residues
in CnCat are shown as a stick model with color representation based on the properties of each amino acid. Hydrophobic, acidic, basic, and hydro-
philic residues are shown in yellow, red, blue, and light blue, respectively. VIVIT is shown in the same representation as in (B).
(D) Schematic representation for the interaction between the PxIxI sequence and hydrophobic pockets of CnCat. The VIVIT peptide binds on the
hydrophobic floor formed by Phe195, Tyr324, Val328, Met329, and Ile331. The conserved PxIxI sequence is accommodated in the hydrophobic
pockets separated by Leu275, Tyr288, Met290, and Phe299. The peptide backbone is represented by the red arrow, and conserved and non-
conserved side chains are shown in dark and light red, respectively.Asn330 (30% of structures) and the guanidine group of
Arg332 (40% of structures), hydrogen-bonding interaction
appears to be the source of the energetic interaction.
To confirm our complex model and rule out the possibil-
ity that the hydrophobic binding pockets for Ile6 and Ile8
may instead accommodate Val5 and Val7 in a different
flipped orientation, selective NOE difference experiments
were performed with a complex of [ul-2H, FIMY-1H] Cn
and [ul-2H15N, Id1LdVg -
1H13C] VIVIT (Reibarkh et al.,
2006; Takahashi et al., 2006). Figure 7A shows the
1H-13C HSQC spectra of [ul-2H, ILV-Me-1H] VIVIT with
and without [ul-2H15N, Id1LdVg -
1H13C] Cn. Chemical-shiftStructure 15,changes upon CnCat binding were more significant for
Ile6 and Ile8 compared to Val5 and Val7, and the reso-
nances of the isoleucines were less intense than the valine
resonances. These results indicate a stronger preference
of Cn for Ile6 and Ile8 over Val5 and Val7, which is consis-
tent with our structural model. Selective irradiation of the
aromatic proton resonances of either Tyr288 or Phe299
selectively saturated the Ile6 and Ile8 methyl resonances
without affecting Val5 and Val7 resonances (Figure 7B).
The quantitative reduction in intensity also showed
a good correlation with the distance between irradiated
and saturated residues. The irradiation of Tyr288 caused587–597, May 2007 ª2007 Elsevier Ltd All rights reserved 593
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Structure of the Calcineurin-NFAT Complexstronger saturation for Ile8 than Ile6, while that of Phe299
decreased the intensity of the Ile6 resonance more than
the Ile8 resonance. These results confirmed the orienta-
tion observed in the determined complex between CnCat
and the VIVIT peptide. A conserved interaction involving
the Thr9 side chain as well as the relative preference of
the hydrophobic pockets for the Ile residues may be the
determining factors for the unique orientation between
CnCat and the VIVIT peptide. In fact, the Ile-Ile pair (e.g.,
Ile8-Ile331) is one of the most preferred amino pairings
in a parallel b sheet (Fooks et al., 2006). In contrast, the
IleHB-ArgnHB pair (i.e., Ile8-Arg332), which would occur
in an alternative flipped interaction, is one of the most
unfavorable pairing of residues in a parallel b sheet.
Figure 7. Chemical-Shift Perturbation and Selective Cross-
Saturation Experiments Using Methyl Selectively Labeled
VIVIT Peptide
(A) HSQC spectra of [ul-2H15N, Id1LdVg -
1H13C] VIVIT peptide with (red)
and without (blue) CnCat. Assignment for each resonance is also
shown.
(B) Selective cross-saturation experiment using [ul-2H15N, Id1LdVg-
1H13C] VIVIT peptide in complex with [U-2H, FIMY-1H] CnCat. Intensity
reduction ratios for each methyl resonance with 250 ms of continuous
wave irradiation to aromatic resonances of Tyr288 and Phe299 are
shown. Average intensity reduction ratios of two g-methyl resonances
are shown for Val resonances. The error bars are estimated from the
signal-to-noise ratios of the resonances analyzed.594 Structure 15, 587–597, May 2007 ª2007 Elsevier Ltd All rigThePxIxIT InteractionOrientsNFAT’sPhosphorylated
Residues toward the Cn Catalytic Site
The topology of the PxIxIT interaction with CnCat raises
the question of how this relates to dephosphorylation
of the regulatory region (Figure 1). All of NFAT’s phosphory-
lation sites are C-terminal to the Cn-binding sequence.
The Cn binding sequence of hNFAT2, for example, is
118-PRIEIT-123 and the dephosphorylation regions are
172-SPASSLSSRSCNSE-185 (serine-rich region 1 [SRR1],
dephosphorylation residues are underlined and bolded),
233-SPRHSPSTSPRA-244 (SPXX-repeat motif 2 [SP2]),
and 278-SPHHSPTPSPHGSP-291 (SP3) (Macian, 2005).
The orientation of the C terminus of the bound VIVIT
peptide (Figure 5) directs the phosphorylated residues to-
ward the catalytic site of Cn. NFAT dephosphorylation is
thought to trigger exposing of the nuclear localization
sequence (NLS), 265-KRK-267, which is N-terminal to
SP3. Although close to the dephosphorylation sites, the
mechanism by which the NLS is activated is not clear with-
out additional structural information. A second potential
second NLS, 682-KRK-684, is located in the C-terminal
domain of NFAT2, but it is unclear how it would be
activated by dephosphorylation of the regulatory domain.
Conclusion
In summary, the structure of CnCat-VIVIT complex was
determined by using NMR-derived constraints and the
known crystal structure of CnCat. The VIVIT peptide forms
a parallel b sheet with the exposed b strand 14 in Cn. The
structure reveals that the bound peptide is oriented to
direct the phosphorylation sites toward the Cn catalytic
site. The conserved PxIxIT sequence is either recognized
by hydrophobic pockets or by forming a side-chain-side-
chain interaction with conserved residues in Cn. These
results provide a detailed view of NFAT recognition by Cn,
providing insight on how Cn specifically recognizes the
conserved PxIxIT motif. The information obtained here
may be useful for developing small compounds that spe-
cifically inhibit the Cn-NFAT interaction. The hydrophobic
pockets of the PVIVIT binding site we characterized in this
study define a target site that could accommodate inhibi-
tors of the CnCat/NFAT interaction. The NMR assignments
established here will provide the means for future charac-
terization of complexes between CnCat and inhibitors,
such as described in Roehrl et al. (2004a).
EXPERIMENTAL PROCEDURES
All chemicals were purchased from Sigma unless otherwise noted.
1-13C amino acids were purchased from Cambridge Isotope Labora-
tories. Celtone base media were purchased from Spectra Stable
Isotopes.
Expression and Purification of the Catalytic Domain
of Human Calcineurin
The catalytic domain of human calcineurin Aa (CnCat), comprising
residues 2–347 with substitutions Y341S, L343A, and M347D (Ara-
mburu et al., 1999), was produced as a cleavable GST fusion protein
in the E. coli strain Rosetta (DE3). Cleavage of the fusion protein with
PreScission protease produces CnCat (2–347) with an additional
GPLG sequence at its N terminus. The CnCat domain obtained ishts reserved
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Structure of the Calcineurin-NFAT Complexenzymatically active as described in our previous publication (Roehrl
et al., 2004b). A crystal structure of the protein prepared in this way
was solved and revealed a structure nearly identical to that of the cat-
alytic domain in full-length calcineurin A including the Fe-Zn cluster
(Michael, 2004). The CnCat protein, uniformly labeled with 2H, 13C,
and 15N, was obtained by growing the E. coli in modified M9 Celtone
medium, which consists of 1 kg/l 99.8% D2O, 8.5 g/l Na2HPO4, 3 g/l
KH2PO4, 0.5 g/l NaCl, 40 mg/l carbenicillin, 15 mg/l chloramphenicol,
1 g/l 15NH4Cl (99.9% enriched), 2 g/l
2H6
13C-glucose (97% enriched),
1 g/l 2H (>97% enriched), 13C (>97% enriched), 15N (>98% enriched)
Celtone Base Powder, 2 mM MgSO4, 0.1 mM CaCl2, 10 mg/l ZnSO4,
and 10 mg/l FeCl3. To obtain the partially
2H- and 15N-labeled CnCat
protein, modified M9 Celtone medium consisting of 1 liter H2O,
8.5 g/l Na2HPO4, 3 g/l KH2PO4, 0.5 g/l NaCl, 40 mg/l carbenicillin,
15 mg/l chloramphenicol, 1 g/l 15NH4Cl (99.9% enriched), 2 g/l
2H6-
glucose (97% enriched), 1g/l 2H (>97% enriched), 15N (>98% enriched)
Celtone Base Powder, 2 mM MgSO4, 0.1 mM CaCl2, 10 mg/l ZnSO4,
and 10 mg/l FeCl3 was used. To obtain selectively labeled CnCat,
E. coli was grown in modified M9 Celtone medium, and targeted
amino acids are added after induction of protein expression at seven
to ten times the amount present in the Celtone media (Spectra Stable
Isotopes) (Takeuchi et al., 2007).
All expression experiments were performed at 37C; after reaching
an OD600 = 0.6, protein expression was induced by the addition of
1 mM IPTG. The cells were harvested after 36–48 hr of induction for
uniformly labeled samples, and after 24 hr for selectively labeled sam-
ples. The harvested cells were resuspended in 40 ml of PBS with 2 mM
dithiothreitol (DTT) and 0.2 mg ml1 phenylmethylsufonylfuruolide
(PMSF) at 4C. The suspended cells were then disrupted by sonication
and the insoluble fraction was removed by centrifugation for 20 min at
15,0003 g. The supernatant was applied to a 5 ml column of Glutathi-
one Sepharose 4 Fast Flow. After washing the resin with 40 ml of PBS
with 2 mM DTT, the CnCat protein was eluted with 40 ml of PBS
containing 2 mM DTT and 25 mM of reduced glutathione. The elution
fraction was concentrated to 20 ml by using 10,000-MWC membrane
ultrafiltration. PreScission protease (0.5 units/20 mg CnCat) was added
to the concentrated elution fraction, and the solution was dialyzed
against 1 l of PBS with 2 mM DTT for 15 hr. The digested solution
was concentrated to 2 ml and subjected to PD-10 desalting column
to remove remaining glutathione. The fractions containing CnCat
were then applied to a 1.5 ml bed volume of Glutathione Sepharose
4 Fast Flow to remove PreScission protease and GST. The elution
protein was further purified with Superedex75 column. Traces of
GST in the Superedex75 elution fractions were then removed by pass-
ing the eluate through 1.5 ml bed volume of Glutathione Sepharose 4
Fast Flow. A typical final yield of CnCat was 2 mg/l culture.
Preparation of the VIVIT Peptide
A synthetic VIVIT 14-mer peptide (H4N-GPHPVIVITGPHEE-COOH,
Tufts-New England Medical Center peptide synthesis facility, Boston,
MA) was used as the nonlabeled form of peptide. The 2H15N13C-
labeled peptide was produced as a GB1 fusion protein in an E. coli
strain, BL21 (DE3). The GB1 fusion protein has the PreScission prote-
ase recognition site between GB1 and VIVIT peptide, which produces
VIVIT (14-mer) with an additional LEHHHHHH purification tag at its
C terminus. For the expression of uniformly 2H15N13C labeled VIVIT
peptide, E. coli harboring the GB1-VIVIT fusion vector was grown in
M9 Celtone medium, which consists of 1 kg/l 99.8% D2O, 8.5 g/l
Na2HPO4, 3 g/l KH2PO4, 0.5 g/l NaCl, 50 mg/l kanamycin, 1 g/l
15NH4Cl (99.9% enriched), 2 g/l
2H6
13C-glucose (97% enriched),
1 g/l 2H (>97% enriched), 13C (>97% enriched), 15N (>98% enriched)
Celtone Base Powder, 2 mM MgSO4, and 0.1 mM CaCl2. The uniformly
2H15N, ILV-methyl 1H13C-labeled ([ul-2H15N, ILV-1H13C-Methyl]) VIVIT
peptide was expressed in M9 minimum medium following the literature
by using [4-1H13C] a-ketobutyrate and [4,4-1H13C] a-ketoisovalerate
(Goto et al., 1999).
The cells were incubated at 37C, and after reaching an OD600 = 0.6,
protein expression was induced by the addition of 1 mM of IPTG. TheStructure 15,cells were harvested after 4–6 hr of induction and were resuspended in
40 ml of buffer A (50 mM Tris-HCl [pH 8.0], 300 mM NaCl, and 20 mM
imidazole) with 0.2 mg/ml PMSF at 4C. The suspended cells were
disrupted by sonication, and the insoluble fraction was removed by
centrifugation at 15,000 3 g for 20 min. The supernatant was applied
to a 5 ml column of Ni-NTA agarose. After washing the resin with 40 ml
of buffer A, the GB1-VIVIT protein was eluted with 40 ml of buffer
consisting of 50 mM Tris-HCl (pH 7.5), 300 mM NaCl, and 300 mM
imidazole. The elution fraction was concentrated to 2 ml by 5000-
MWC-membrane ultrafiltration. PreScission protease and 1 mM DTT
were added to the concentrated elution fraction. The digested solution
was purified on a Superedex75 column. The final yield of the VIVIT
peptide was 20 mg/l culture.
NMR Spectroscopy
All experiments were performed on a Bruker Avance 750 spectrometer
equipped with a cryogenic probe. All spectra were collected with 0.4–
0.6 mM protein in 10 mM sodium phosphate buffer (pH 6.8) containing
150 mM NaCl, 2 mM DTT, and 90% H2O/10% D2O at 298 K. Spectra
were processed by using XWINNMR and analyzed with Sparky
(Goddard and Kneller, 2006). The backbone assignment of CnCat in
complex with the VIVIT peptide was accomplished by using standard
TROSY triple-resonance experiments (Ferentz and Wagner, 2000). A
500 mM sample of uniformly 2H-, 13C-, and 15N-labeled CnCat mixed
with 1.2 molar excess of the nonlabeled VIVIT peptide was prepared.
To confirm the assignments, four samples of perdeuterated 15N-
labeled CnCat amino acid specifically labeled with unlabeled Arg,
Lys, or 1-13C Val and 1-13C Leu were prepared. The backbone assign-
ment of the VIVIT peptide in free form and in complexed with CnCat
was accomplished by using standard triple-resonance experiment
without and with TROSY pulse scheme, respectively (Ferentz and
Wagner, 2000). For the observation of free VIVIT spectra, a 500 mM
concentration of 2H-, 13C-, and 15N-labeled VIVIT was prepared. To
record spectra of VIVIT in complex with CnCat, 2H-, 13C-, and 15N-
labeled peptide was complexed with 1.2 molar excess of nonlabeled
CnCat. For the assignment of the proton resonances of the VIVIT
peptide, 1H-TOCSY and 1H-NOESY (100 ms mixing time) spectra
were recorded for the nonlabeled VIVIT peptide in complex with
[U-2H15N13C] CnCat. To obtain the main-chain-main-chain and
main-chain-side-chain intermolecular NOE between VIVIT and CnCat,
15N-NOESY-HSQC spectra with 200 ms mixing time were recorded for
2H15N13C labeled VIVIT peptide or CnCat in the presence of a slight
excess amount of nonlabeled binding partner (Gross et al., 2003).
Side-chain-side-chain NOEs were obtained from recording a 13C-
NOESY-HSQC spectrum with 200 ms mixing time of a complex of
[ul-2H15N, Id1LdVg -
1H13C] VIVIT peptide and [2H, FIMY-1H] CnCat.
Cross-saturation experiments were performed in accordance with
previous literature (Takahashi et al., 2006; Takahashi et al., 2000).
Structure Determination of CnCat-VIVIT Complex
The structure of the CnCat-VIVIT complex was determined by simu-
lated annealing of the VIVIT peptide in the presence of the X-ray struc-
ture of free CnCat (Kissinger et al., 1995) (PDB code: 1AIU) by using
structural information derived from NMR spectroscopy. The experi-
mental restraints include 22 intermolecular distance restraints be-
tween CnCat and VIVIT peptide, 52 intramolecular distance restraints
within VIVIT peptide, and 9 main-chain angular constraints for I6-G10
in VIVIT peptide. While calculating the structure, CnCat was modeled
by main-chain and side-chain angular restraints as well as amide-
amide, amide-alpha, and alpha-alpha intramolecular proton-proton
distance restraints and hydrogen-bonding restraints calculated from
X-ray structure of free CnCat (21–347). The side chains of the residues
near the VIVIT peptide binding sites in CnCat were left flexible by not
applying the angular restraints. The final structures, with statistical
results shown in Table 1, were calculated by using CYANA. We ran
100 sets of the final structure calculations with all of the determined
structural constraints and chose the ten best structures based on
lowest energy function, no NOE violations >0.5 A˚, and no angular587–597, May 2007 ª2007 Elsevier Ltd All rights reserved 595
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Structure of the Calcineurin-NFAT Complexviolations >5. The structures were analyzed with the PROCHECK-
NMR (Laskowski et al., 1996) and MOLMOL (Koradi et al., 1996)
programs. The solvent-accessible surface area for amino acid residues
was calculated with a solvent radius of 1.4 A˚ with the MOLMOL pro-
gram. Structural figures were generated with the MOLMOL program.
Supplemental Data
Supplemental Data describing experimental restraints applied for the
structure calculations are available at http://www.structure.org/cgi/
content/full/15/5/587/DC1/.
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